Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis

References

• Niederkorn JY, Kaplan HJ. Rationale for immune response and the eye. Chem Immunol Allergy. 2007;92:1–3.
   PubMedGoogle Scholar
• Sandhu HS, Kaplan HJ. Clinical Cases in Uveitis. Differential Diagnosis and Management. 1st ed. Philadelphia: Elsevier; 2021:1–8.
   Google Scholar
• Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT. Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion. Retina. 2006;26(Suppl):1–16. doi:10.1097/01.iae.0000250601.15893.5f.
   PubMedGoogle Scholar
• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236. doi:10.1159/000078612.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249(1):158–175. doi:10.1111/j.1600-065X.2012.01146.x.
   PubMed Web of Science ®Google Scholar
• Sirisinha S. Insight into the mechanisms regulating immune homeostasis in health and disease. Asian Pac J Allergy Immunol. 2011;29:1–14.
   PubMed Web of Science ®Google Scholar
• Abdelsadik A, Trad A. Toll-like receptors on the fork roads between innate and adaptive immunity. Hum Immunol. 2011;72(12):1188–1193. doi:10.1016/j.humimm.2011.08.015.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35–46. doi:10.1111/j.1600-065X.2007.00574.x.
   PubMed Web of Science ®Google Scholar
• Bianchi ME. HMGB1 loves company. J Leukocyte Biol. 2009;86(3):573–576. doi:10.1189/jlb.1008585.
   PubMed Web of Science ®Google Scholar
• Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 2003;21:S44–S8.
   PubMed Web of Science ®Google Scholar
• Tang DL, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Sign. 2011;14(7):1315–1335. doi:10.1089/ars.2010.3356.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Terkeltaub R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous toll-like receptor 2/toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheumatism. 2010;62:2004–2012.
   PubMed Web of Science ®Google Scholar
• Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Brit J Ophthalmol. 2010;94(3):271–274. doi:10.1136/bjo.2008.146753.
   PubMed Web of Science ®Google Scholar
• Song PI, Abraham TA, Park Y, et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci. 2001;42(12):2867–2877.
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci. 2004;45(6):1871–1878. doi:10.1167/iovs.03-1113.
   PubMed Web of Science ®Google Scholar
• Chui JJY, Li MWM, Di Girolamo N, Chang JH, McCluskey PJ, Wakefield D. Iris pigment epithelial cells express a functional lipopolysaccharide receptor complex. Invest Ophth Vis Sci. 2010;51(5):2558–2567. doi:10.1167/iovs.09-3923.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Sonoda KH, Hijioka K, et al. Choroidal neovascularization enhanced by chlamydia pneumoniae via toll-like receptor 2 in the retinal pigment epithelium. Invest Ophth Vis Sci. 2010;51(9):4694–4702. doi:10.1167/iovs.09-4464.
   PubMed Web of Science ®Google Scholar
• Ko MK, Saraswathy S, Parikh JG, Rao NA. The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest Ophth Vis Sci. 2011;52(8):5824–5835. doi:10.1167/iovs.10-6357.
   PubMed Web of Science ®Google Scholar
• Jiang GM, Ke Y, Sun DM, Wang YL, Kaplan HJ, Shao H. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest Ophth Vis Sci. 2009;50(10):4769–4776. doi:10.1167/iovs.08-3303.
   PubMed Web of Science ®Google Scholar
• Jiang GM, Sun DM, Kaplan HJ, Shao H. Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells. Plos One. 2012;7:7.
   Web of Science ®Google Scholar
• Luo C, Yang XJ, Kain AD, Powell DW, Kuehn MH, Tezel G. Glaucomatous tissue stress and the regulation of immune response through glial toll- like receptor signaling. Invest Ophth Vis Sci. 2010;51(11):5697–5707. doi:10.1167/iovs.10-5407.
   PubMed Web of Science ®Google Scholar
• Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Mol Med. 2008;14(7–8):476–484. doi:10.2119/2008-00034.Klune.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang HC, Ding AH, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006;26(2):174–179. doi:10.1097/01.shk.0000225404.51320.82.
   PubMed Web of Science ®Google Scholar
• Yang HA, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. P Natl Acad Sci USA. 2010;107(26):11942–11947. doi:10.1073/pnas.1003893107.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Jiang W. Role of toll-like receptors in HMGB1 release from macrophages. Ann Ny Acad Sci. 2007;1109:58–65. doi:10.1196/annals.1398.008.
   PubMed Web of Science ®Google Scholar
• Tian J, Avalos AM, Mao SY, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE (vol 8, pg 487, 2007). Nat Immunol. 2007;8(7):780. doi:10.1038/ni0707-780b.
   Web of Science ®Google Scholar
• Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness - Functional inactivation of rage in L6 myoblasts results in tumor formation in vivo. J Biol Chem. 2006;281(12):8242–8253. doi:10.1074/jbc.M509436200.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang HC, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukocyte Biol. 2005;78(1):1–8. doi:10.1189/jlb.1104648.
   PubMed Web of Science ®Google Scholar
• Voll RE, Urbonaviciute V, Herrmann M, Kalden JR. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr Med Assoc J. 2008;10:26–28.
   PubMed Web of Science ®Google Scholar
• Han JY, Zhong JX, Wei WZ, et al. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes. 2008;57(8):2118–2127. doi:10.2337/db07-1499.
   PubMed Web of Science ®Google Scholar
• Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Bba-Mol Cell Res. 1998; 1448(2):200–211.
   PubMed Web of Science ®Google Scholar
• Leach ST, Yang Z, Messina I, et al. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42(11):1321–1331. doi:10.1080/00365520701416709.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Ren Z, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008;216(2):183–192. doi:10.1002/path.2394.
   PubMed Web of Science ®Google Scholar
• Van Lent PLEM, Blom AB, Schelbergen RFP, et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheumatism. 2012;64(5):1466–1476. doi:10.1002/art.34315.
   PubMed Web of Science ®Google Scholar
• Schelbergen RFP, Blom AB, Van den Bosch MHJ, et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on toll-like receptor 4. Arthritis Rheumatism. 2012;64(5):1477–1487. doi:10.1002/art.33495.
   PubMed Web of Science ®Google Scholar
• Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006;72(11):1622–1631. doi:10.1016/j.bcp.2006.05.017.
   PubMed Web of Science ®Google Scholar
• Sunahori K, Yamamura M, Yamana J, et al. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther. 2006;8:3. doi:10.1186/ar1939.
   Web of Science ®Google Scholar
• Loser K, Vogl T, Luger TA, Roth J, Beissert S. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8(+) T cells. J Investigative Dermatol. 2010;130:S4–S.
   Web of Science ®Google Scholar
• Shao H, Liao TJ, Ke Y, Shi HS, Kaplan HJ, Sun DM. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp Eye Res. 2006;82(2):323–331. doi:10.1016/j.exer.2005.07.008.
   PubMed Web of Science ®Google Scholar
• Shao H, Lei S, Sun SL, Kaplan HJ, Sun DM. Conversion of monophasic to recurrent autoimmune disease by autoreactive T cell subsets. J Immunol. 2003;171(10):5624–5630. doi:10.4049/jimmunol.171.10.5624.
   PubMed Web of Science ®Google Scholar
• Epps SJ, Boldison J, Stimpson ML, et al. Re-programming immunosurveillance in persistent non-infectious ocular inflammation. Prog Retin Eye Res. 2018;65:93–106. doi:10.1016/j.preteyeres.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Caspi R. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells. Immunol Res. 2008;42(1–3):41–50. doi:10.1007/s12026-008-8031-3.
   PubMed Web of Science ®Google Scholar
• Caspi RR, Roberge FG, Mcallister CG, et al. T-cell lines mediating experimental autoimmune uveoretinitis (Eau) in the rat. J Immunol. 1986;136(3):928–933.
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Bahmanyar S, Mahdi RM, Nussenblatt RB, Gery I, Caspi RR. Predominant usage of V-Beta-8.3 T-cell receptor in a T-cell line that induces experimental autoimmune uveoretinitis (Eau). Clin Immunol Immunop. 1992;65(2):152–160. doi:10.1016/0090-1229(92)90218-D.
   PubMedGoogle Scholar
• Shao H, Shi HS, Kaplan HJ, Sun DM. Chronic recurrent autoimmune uveitis with progressive photoreceptor damage induced in rats by transfer of IRBP-specific T cells. J Neuroimmunol. 2005;163(1–2):102–109. doi:10.1016/j.jneuroim.2005.03.004.
   PubMed Web of Science ®Google Scholar
• Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120(9):3073–3083. doi:10.1172/JCI42440.
   PubMed Web of Science ®Google Scholar
• Caspi RR. Immune mechanisms in uveitis. Springer Semin Immun. 1999;21(2):113–124. doi:10.1007/BF00810244.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Taguchi M, Sato T, et al. Association of high-mobility group box-1 with Th cell-related cytokines in the vitreous of ocular sarcoidosis patients. Invest Ophthalmol Vis Sci. 2017;58(1):528–537. doi:10.1167/iovs.16-20324.
   PubMed Web of Science ®Google Scholar
• Mendes D, Correia M, Barbedo M, et al. Behcet’s disease - a contemporary review. J Autoimmun. 2009;32(3–4):178–188. doi:10.1016/j.jaut.2009.02.011.
   PubMed Web of Science ®Google Scholar
• de Souza AWS, Perazzio SF, de Franca NR, et al. High mobility group box 1 serum levels are increased in Behcet’s disease, but not associated with disease activity or disease manifestations. Rheumatology. 2015;54(12):2151–2155.
   PubMed Web of Science ®Google Scholar
• Ahn JK, Cha HS, Bae EK, Lee J, Koh EM. Extracellular high-mobility group box 1 is increased in patients with behcet’s disease with intestinal involvement. J Korean Med Sci. 2011;26(5):697–700. doi:10.3346/jkms.2011.26.5.697.
   PubMed Web of Science ®Google Scholar
• van der Houwen TB, Dik WA, Goeijenbier M, et al. Leukocyte toll-like receptor expression in pathergy positive and negative Behcet’s disease patients. Rheumatology. 2020;59(12):3971–3979. doi:10.1093/rheumatology/keaa251.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Keino H, Sato Y, Kudo A, Kawakami H, Okada AA. High mobility group box protein-1 in experimental autoimmune uveoretinitis. Invest Ophth Vis Sci. 2009;50(5):2283–2290. doi:10.1167/iovs.08-2709.
   PubMed Web of Science ®Google Scholar
• Jiang GM, Sun DM, Yang H, Lu QX, Kaplan HJ, Shao H. HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells. J Leukoc Biol. 2014;95(4):599–607. doi:10.1189/jlb.0613337.
   PubMed Web of Science ®Google Scholar
• Wang F, Lu ZY, Hawkes M, Yang HA, Kain KC, Liles WC. Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages. J Inflamm-Lond. 2010;7.
   Web of Science ®Google Scholar
• Abu El-Asrar AM, Dralands L, Missotten L, Al-Jadaan I, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophth Vis Sci. 2004;45(8):2760–2766. doi:10.1167/iovs.03-1392.
   PubMed Web of Science ®Google Scholar
• Esser P, Heimann K, Abts H, Fontana A, Weller M. Cd95 (Fas/Apo-1) antibody-mediated apoptosis of human retinal-pigment epithelial-cells. Biochem Bioph Res Co. 1995;213(3):1026–1034. doi:10.1006/bbrc.1995.2231.
   PubMed Web of Science ®Google Scholar
• Jiang GM, Wang YS, Yun J, et al. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent. J Neuroinflamm. 2015;12. doi:10.1186/s12974-015-0389-2.
   Web of Science ®Google Scholar
• Yun J, Jiang GM, Wang YS, et al. The HMGB1-CXCL12 complex promotes inflammatory cell infiltration in uveitogenic T cell-induced chronic experimental autoimmune uveitis. Front Immunol. 2017;8. doi:10.3389/fimmu.2017.00142.
   Web of Science ®Google Scholar
• Yang H, Ochani M, Li JH, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. P Natl Acad Sci USA. 2004;101(1):296–301. doi:10.1073/pnas.2434651100.
   PubMed Web of Science ®Google Scholar
• Chung KY, Park JJ, Kim YS. The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate. Transpl P. 2008;40(7):2136–2138. doi:10.1016/j.transproceed.2008.06.040.
   PubMed Web of Science ®Google Scholar
• Mollica L, De Marchis F, Spitaleri A, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007;14(4):431–441. doi:10.1016/j.chembiol.2007.03.007.
   PubMedGoogle Scholar
• Wang YQ, Zhang ZH, Zhang LH, et al. S100A8 promotes migration and infiltration of inflammatory cells in acute anterior uveitis. Sci Rep-Uk. 2016;6:36140. doi:10.1038/srep36140.
   Web of Science ®Google Scholar
• Wang YQ, Dai XD, Ran Y, et al. Circulating S100A8/A9 levels reflect intraocular inflammation in uveitis patients. Ocul Immunol Inflamm. 2020;28(1):133–141. doi:10.1080/09273948.2018.1538461.
   PubMed Web of Science ®Google Scholar
• Walscheid K, Heiligenhaus A, Holzinger D, et al. Elevated S100A8/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study. Invest Ophth Vis Sci. 2015;56(13):7653–7660. doi:10.1167/iovs.15-17066.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Yeh S, Patel P, et al. Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study. J Ophthalmic Inflamm. 2018;8.
   PubMed Web of Science ®Google Scholar
• Pascual EV, Perez LMC, Pons AH, et al. The role of plasma calprotectin in non-infectious uveitis. Curr Eye Res. 2021:1–9. doi:10.1080/02713683.2020.1867749.
   Web of Science ®Google Scholar
• Wang L, Rose CD, Foley KP, et al. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology. 2018;57(7):1299–1304. doi:10.1093/rheumatology/key090.
   PubMed Web of Science ®Google Scholar
• Kasper M, Walscheid K, Laffer B, et al. The phenotype of monocytes in anterior uveitis depends on the hla-B27 status. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.01773.
   Web of Science ®Google Scholar
• Kasper M, Walscheid K, Laffer B, et al. Phenotype of innate immune cells in uveitis associated with axial spondyloarthritis- and juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2020:1–10. doi:10.1080/09273948.2020.1715449.
   Web of Science ®Google Scholar
• Deininger MH, Zhao YH, Schluesener HJ. CP-10, a chemotactic peptide, is expressed in lesions of experimental autoimmune encephalomyelitis, neuritis, uveitis and in C6 gliomas. J Neuroimmunol. 1999;93(1–2):156–163. doi:10.1016/S0165-5728(98)00221-5.
   PubMed Web of Science ®Google Scholar
• Pepple KL, Rotkis L, Wilson L, Sandt A, Van Gelder RN. Comparative proteomic analysis of two uveitis models in lewis rats. Invest Ophth Vis Sci. 2015;56(13):8449–8456. doi:10.1167/iovs.15-17524.
   PubMed Web of Science ®Google Scholar
• Yun J, Xiao T, Zhou L, et al. Local S100A8 levels correlate with recurrence of experimental autoimmune uveitis and promote pathogenic T cell activity. Invest Ophth Vis Sci. 2018;59(3):1332–1342. doi:10.1167/iovs.17-23127.
   PubMed Web of Science ®Google Scholar